雲南鍺業(002428.SZ):鑫耀公司化合物半導體材料產品砷化鎵晶片(襯底)、磷化銦晶片(襯底)均已批量生產
格隆匯11月15日丨雲南鍺業(002428.SZ)在投資者互動平台表示,公司子公司鑫耀公司化合物半導體材料產品砷化鎵晶片(襯底)、磷化銦晶片(襯底)均已批量生產,並已向國內外多家客户供貨。截至目前鑫耀公司砷化鎵晶片產能為80萬片/年(2—4英寸),磷化銦晶片產能為15萬片/年(2—4英寸)。Yole發佈過關於砷化鎵晶片(襯底)、磷化銦晶片(襯底)的市場佔有率情況,請查閲相關報吿;上述報吿系第三方發佈,並不代表公司觀點,請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.